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Antibiotic resistance and biofilm-forming capacity contribute to the success of
Staphylococcus aureus as a human pathogen in both healthcare and community settings.
These virulence factors do not function independently of each other and the biofilm
phenotype expressed by clinical isolates of S. aureus is influenced by acquisition of
the methicillin resistance gene mecA. Methicillin-sensitive S. aureus (MSSA) strains
commonly produce an icaADBC operon-encoded polysaccharide intercellular adhesin
(PIA)-dependent biofilm. In contrast, the release of extracellular DNA (eDNA) and cell
surface expression of a number of sortase-anchored proteins, and the major autolysin
have been implicated in the biofilm phenotype of methicillin-resistant S. aureus (MRSA)
isolates. Expression of high level methicillin resistance in a laboratory MSSA strain resulted
in (i) repression of PIA-mediated biofilm production, (ii) down-regulation of the accessory
gene regulator (Agr) system, and (iii) attenuation of virulence in murine sepsis and device
infection models. Here we review the mechanisms of MSSA and MRSA biofilm production
and the relationships between antibiotic resistance, biofilm and virulence gene regulation
in S. aureus.
Keywords: biofilm, LPXTG proteins, Atl, PIA, mecA, methicillin resistance, c-di-AMP, Staphylococcus aureus
BIOFILM FORMATION BY STAPHYLOCOCCI AND ITS
MEDICAL SIGNIFICANCE
Implantable medical devices have revolutionized modern health-
care; however attachment to these devices by surface adhering
bacteria resulting in biofilm formation and device related infec-
tions (DRIs) substantially impact patient morbidity and mor-
tality. Biofilms formed by staphylococci have for many decades
been recognized as the most frequent cause of biofilm-associated
infections with Staphylococcus epidermidis and S. aureus being
among the most common etiologic agents of DRIs (Davies, 2003;
Otto, 2013). Infections associated with biofilms are difficult to
treat because the biofilm matrix and phenotypic characteristics
of the bacteria confer resistance to the host immune response
and the action of antimicrobial drugs (O’Gara and Humphreys,
2001).
All implanted medical devices are susceptible to colonization
by staphylococci and staphylococcal biofilm-associated infec-
tions have been associated with devices ranging from implanted
catheters to prosthetic heart valves, cardiac pacemakers, con-
tact lenses, cerebrospinal fluid shunts, joint replacements and
intravascular lines (Donlan and Costerton, 2002; Hall-Stoodley
et al., 2004). Damaged host tissue is also a risk factor for devel-
oping biofilm-associated infection. S. epidermidis and S. aureus,
which are part of the normal skin flora are opportunistic
pathogens that can cause deep-seated skin infections for exam-
ple in burn or post-operative wounds (Hammond et al., 2011).
They are also known to form biofilms on damaged heart valves,
leading to the development of life-threatening infective endo-
carditis (Claret et al., 2007; Nethercott et al., 2013).
S. epidermidis, unlike the more virulent S. aureus, relies
almost exclusively on its ability to colonize and form biofilms
on implanted medical devices to cause clinical infections (O’Gara
and Humphreys, 2001; Christner et al., 2012) and a strong corre-
lation has been reported between the pathogenicity of S. epider-
midis and its ability to colonize implantedmedical devices (Vuong
and Otto, 2002). The ability of S. aureus to form biofilms on
implanted medical devices or damaged host tissue is also a key
virulence factor for this pathogen, especially in healthcare set-
tings where antibiotic usage is high and such biofilm formation
represents a survival mechanism for the bacteria (Høiby et al.,
2010). Among the most studied mechanism of biofilm formation
is the production of the icaADBC operon-encoded polysaccha-
ride intercellular adhesion (PIA) or poly-N-acetylglucosamine
(PNAG) by both S. aureus and S. epidermidis (O’Gara, 2007;
Joo and Otto, 2012). However, biofilm formation independent
of the ica operon has also been described in both S. epider-
midis and S. aureus (Hussain et al., 1997; Fitzpatrick et al.,
2005; Tormo et al., 2005; Qin et al., 2007; O’Neill et al., 2008;
Schroeder et al., 2009; Shahrooei et al., 2009; Geoghegan et al.,
2010).
In this review, we describe different mechanisms used by
methicillin-sensitive S. aureus (MSSA) and methicillin-resistant
S. aureus (MRSA) isolates to form biofilm and how the acqui-
sition or loss of methicillin resistance impacts on, not only the
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biofilm phenotype of S. aureus, but also on global gene regulation
and virulence.
BIOFILM FORMATION BY METHICILLIN-SENSITIVE
S. AUREUS
The first described mechanism of S. aureus biofilm formation
involved PIA/PNAG production (Cramton et al., 1999, 2001)
that had earlier been described in S. epidermidis (Mack et al.,
1994; Heilmann et al., 1996a,b; Heilmann and Götz, 1998). PIA is
a glycan of β-1,6-linked 2-acetamido-2-deoxy-D-glucopyranosyl
residues with a net positive charge that promotes intercellular
aggregation and attachment of cells to inert surfaces (Rohde
et al., 2010). The ica operon consists of four biosynthesis genes,
icaA, icaD, icaB, and icaC and a divergently transcribed repres-
sor, icaR (Conlon et al., 2002; Götz, 2002). The majority of
research on the activity of the ica locus has been conducted
in S. epidermidis but there is high nucleotide sequence homol-
ogy between the ica loci of S. epidermidis and S. aureus and
78% identity at the amino acid level (Cramton et al., 1999).
An early study demonstrated that a transposon mutation in the
ica operon of S. epidermidis impaired biofilm formation and
PIA production (Heilmann et al., 1996b). Subsequent studies
showed that S. aureus also commonly uses icaADBC-encoded
PIA as a mechanism of biofilm formation (Cramton et al., 1999,
2001).
Carriage of the ica locus is a characteristic of most clini-
cal S. aureus strains (Cramton et al., 1999; Fowler et al., 2001;
Rohde et al., 2001). One of the first reports of PNAG-independent
S. aureus biofilm production was described in bovine mastitis
isolates, which formed biofilm mediated by the biofilm asso-
ciated protein (Bap) (Cucarella et al., 2001, 2004). An early
study with the human S. aureus isolate UAMS-1, also revealed
an icaADBC-independent biofilm phenotype under in vitro and
in vivo conditions (Beenken et al., 2004).
Investigations into PIA-dependent and PIA-independent
mechanisms of biofilm formation identified a correlation
between methicillin susceptibility and biofilm in S. aureus
(Fitzpatrick et al., 2005; O’Neill et al., 2007, 2008; Houston
et al., 2011). This relationship between the biofilm phenotype
and β-lactam susceptibility was first investigated in S. epider-
midis by Mempel et al. who reported that variable levels of PIA
production were significantly associated with different levels of
β-lactam susceptibility in phenotypic variants (Mempel et al.,
1994, 1995). The significant association between methicillin sus-
ceptibility in S. aureus and ica-dependent biofilm formation was
first reported when PIA production was found to be essential for
biofilm formation by MSSA but not MRSA (O’Neill et al., 2007).
MSSA biofilms are significantly induced in growth media supple-
mented with NaCl, which is known to activate ica operon expres-
sion (Fitzpatrick et al., 2006; O’Neill et al., 2007). Furthermore,
MSSA biofilms are susceptible to sodium metaperiodate treat-
ment (which oxidizes polysaccharide bonds) and are resistant to
treatment with proteinase K (O’Neill et al., 2007). Deletion of
the ica locus abolished biofilm-forming capacity among clinical
MSSA isolates that are amenable to genetic manipulation, as did
mutation of the staphylococcal accessory regulator sarA (Valle
et al., 2003; O’Neill et al., 2007).
Building on an original finding that four clinical MRSA iso-
lates were capable of producing icaADBC-independent biofilm
(Fitzpatrick et al., 2005), our laboratory reported differences in
the environmental regulation of biofilm formation among 32
S. aureus isolates from intensive care units (15 MSSA and 17
MRSA strains) and found that NaCl-induced, PIA-dependent
biofilm was more likely to be associated with MSSA biofilm for-
mation (Fitzpatrick et al., 2006). A follow-up study of a large
collection of 212 S. aureus isolates from device-related infections
(114 MRSA and 98 MSSA) representing five clonal complexes
(CC5, CC8, CC22, CC30, and CC45) further demonstrated that
MSSA strains were more likely to produce NaCl-induced, PIA-
mediated biofilm whereas MRSA biofilm was induced in media
supplemented with glucose and was PIA-independent (O’Neill
et al., 2007).
BIOFILM FORMATION BY MRSA STRAINS
The ica locus was found to be redundant for MRSA biofilm for-
mation (O’Neill et al., 2007). Unlike the NaCl-induced biofilm
expressed by MSSA clinical isolates, biofilm formation by MRSA
isolates was significantly more likely to be induced by the addi-
tion of glucose to the growth medium, which is associated with
the acidification of the culture media (O’Neill et al., 2007).
MRSA biofilms are resistant to sodium metaperiodate treat-
ment but are susceptible to proteinase K treatment, implicat-
ing protein adhesins in this biofilm phenotype (O’Neill et al.,
2007).
As observed in MSSA isolates, mutation in sarA also abol-
ished biofilm formation by clinical MRSA isolates (Beenken et al.,
2004; O’Neill et al., 2007). SarA is a known repressor of four
major extracellular proteases, namely SspA, SspB, Aur, and ScpA
(Karlsson et al., 2001) and it is proposed that impaired glucose-
induced biofilm formation by MRSA sarA mutants may be asso-
ciated with upregulation of protease activity, which can inhibit
S. aureus biofilm production (Marti et al., 2010).
A deletion in the accessory gene regulator (agr) system
enhanced biofilm formation by clinical MRSA strains but had
no significant effect on biofilms formed by MSSA strains
(O’Neill et al., 2007). In contrast to sarA, agr positively regu-
lates expression of the four major proteases (Shaw et al., 2004).
Additionally, mutations in the agr-regulated Aur metalloprotease
and the SplABCDEF serine proteases increased biofilm formation
and reduced detachment from established biofilms (Boles and
Horswill, 2008). Similarly, the serine protease inhibitor phenyl-
methylsulfonyl fluoride (PMSF) enhanced biofilm formation,
further implicating increased protease activity as the mechanism
of agr-mediated dispersal from biofilms (Boles and Horswill,
2008). The positive impact of an agr mutation on MRSA biofilm
formation is largely consistent with other research showing that
deletion of agr can enhance S. aureus biofilm formation (Vuong
et al., 2000; Beenken et al., 2003), whilst a separate study demon-
strated that agr deletion does not significantly alter icaADBC
expression or PIA production (Vuong et al., 2003). Interestingly,
the reduced pH of cultures grown in media supplemented with
glucose, was associated with repression of the agr system (Regassa
et al., 1992). Furthermore, activation of the agr system was shown
to initiate biofilm dispersal (Boles and Horswill, 2008). The
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agr locus encodes two divergent transcripts, RNAII and RNAIII
driven by the P2 and P3 promoters, respectively (Novick et al.,
1993). RNAII comprises four genes, agrBDCA, that encode for the
synthesis of secreted autoinducing peptide AIP. At threshold con-
centrations, AIP binds to the sensor histidine kinase AgrC, which
phosphorylates AgrA and activates the P2 and P3 promoters,
resulting in upregulated agr expression and increased transcrip-
tion of the RNAIII effector molecule. Exogenous addition of
AIP to biofilms induced dispersal from established biofilms by
upregulating the agr system and subsequently increasing protease
production (Boles and Horswill, 2008). The enhanced biofilm
phenotype observed in agr mutants is also attributed to the
loss of production of the RNAIII-encoded delta-toxin, which has
surfactant properties (Vuong et al., 2000, 2004). Biofilm detach-
ment by agr+ strains is proposed to require the formation of
a film of amphipathic delta-toxin molecules expressed at the
biofilm/fluid interface which can inhibit the hydrophobic interac-
tions between bacterial cell surfaces, thus lowering surface tension
and causing cell detachment from the biofilm matrix (Vuong
et al., 2004).
ROLE OF LPXTG-ANCHORED SURFACE PROTEINS IN MRSA BIOFILM
FORMATION
S. aureus expresses 28 surface proteins, 21 of which are predicted
to contain LPXTG binding motifs required for normal display
on the cell surface (Ton-That et al., 2000; Mazmanian et al.,
2001). Anchoring of these LPXTG motif-containing proteins to
peptidoglycan is catalyzed by Sortase, an extracellular transpepti-
dase encoded by the srtA gene (Mazmanian et al., 2000). A srtA
mutation affected biofilm accumulation by clinical MRSA strains
from three clonal complexes and had no impact on ica-dependent
biofilms formed by MSSA strains (O’Neill et al., 2008). As noted
earlier Bap was the first LPXTG-anchored surface protein impli-
cated in ica-independent S. aureus biofilm formation but is rarely
found in human isolates (Cucarella et al., 2001; Tormo et al.,
2005).
The fibronectin-binding proteins (FnBPs) were subsequently
shown to play an important role in ica-independent biofilm for-
mation by human MRSA isolates (O’Neill et al., 2008; Shanks
et al., 2008; Vergara-Irigaray et al., 2009). The FnBPs are multi-
functional surface proteins with an N-terminal A domain and
a C-terminal wall spanning LPXTG-anchoring domain sepa-
rated by tandem repeats involved in binding to fibronectin
(Schwarz-Linek et al., 2003; Meenan et al., 2007). Both FnBP
proteins, FnBPA and FnBPB, are involved in the accumula-
tion phase of MRSA biofilm formation in hospital and com-
munity isolates under static and flow conditions, with each
individual protein capable of complementing the biofilm defect
of a double fnbpAB mutant (O’Neill et al., 2008; McCourt
et al., 2014). The FnBPs do not contribute to PIA-mediated
biofilm formation by clinical MSSA strains (O’Neill et al., 2008).
Expression of the FnBPs was constitutive in a MRSA isolate
producing an FnBP-dependent biofilm but restricted to the expo-
nential growth phase in MSSA isolates that form PIA biofilms
(Geoghegan et al., 2013). The N-terminal of the FnBPA pro-
tein, specifically residues 166–498 comprising the N2 and N3
subdomains of the A domain, has been implicated in the
biofilm phenotype via a Zn(2+)-dependent mechanism (O’Neill
et al., 2008; Geoghegan et al., 2013). A separate study from
the Lasa laboratory, demonstrated that MRSA strain 132 was
capable of producing either acid stress-induced FnBP-dependent
biofilm or osmotic stress-induced exopolysaccharide-mediated
biofilm (Vergara-Irigaray et al., 2009). Furthermore, the 132
fnbpABmutant displayed significantly impaired colonization and
biofilm formation compared to the isogenic 132 ica mutant
in a murine model of subcutaneous catheter-related infection
(Vergara-Irigaray et al., 2009). Recently the formation of bac-
terial biofilm-like aggregates in human synovial fluid by MRSA
and MSSA strains was attributed to expression of the FnBPs as
well as the fibrinogen binding proteins ClfA and ClfB, identify-
ing biofilm and in particular LPXTG-wall anchored proteins as
important virulence determinants in staphylococcal joint infec-
tions (Dastgheyb et al., 2014).
In MRSA strains where the FnBPs have not (yet) been impli-
cated in protein dependent biofilm, a number of other LPXTG
proteins may be important. The accumulation associated protein
(Aap), which is 54% identical to the SasG protein of S. aureus
(Corrigan et al., 2007) was first identified in S. epidermidis and
is known to play a well-defined role in the biofilm phenotype
(Hussain et al., 1997; Rohde et al., 2005; Conrady et al., 2008,
2013; Conlon et al., 2014; Schaeffer et al., 2015). SasG, which
is found in approximately 50% of human clinical isolates, has
also been implicated in the intercellular accumulation phase of
ica-independent biofilm formation (Corrigan et al., 2007; Sung
et al., 2008). SasG promotes intercellular aggregation via homo-
oligomerization of the SasG protein (Kuroda et al., 2008) with
biofilm formation promoted by the repeated B domains of the
SasG protein (Geoghegan et al., 2010). The B repeat regions pro-
mote ica-independent biofilm formation in a Zn(2+)-dependent
manner through the formation of extended fibrils on the cell sur-
face (Geoghegan et al., 2010; Gruszka et al., 2012). Protein A also
promotes polysaccharide-independent biofilm but does not need
to be anchored to the cell wall via its LPXTG motif to do so, with
exogenous Protein A capable of promoting biofilm accumulation
(Merino et al., 2009). However, the role or otherwise of SasG and
protein A to staphylococcal biofilm-associated infections has not
yet been investigated. Readers are referred to a companion review
in this series focusing on staphylococcal proteinaceous biofilms
by Pietro Speziale.
ROLE OF THE MAJOR AUTOLYSIN AND EXTRACELLULAR DNA IN MRSA
BIOFILM FORMATION
The major autolysin, Atl, which is involved in daughter cell sepa-
ration, cell wall homeostasis and peptidoglycan turnover (Yamada
et al., 1996; Biswas et al., 2006) plays a role in the early stages
of ica-independent biofilm formation by clinical MRSA strains
(Houston et al., 2011). This bifunctional peptidoglycan hydrolase
was first implicated in the primary attachment of S. epidermidis
to polystyrene (Heilmann et al., 1997; Biswas et al., 2006), with
atlE mutants exhibiting significantly attenuated virulence in a
rat central venous catheter infection model (Rupp et al., 2001).
AtlE of S. epidermidis also possesses vitronectin-binding activ-
ity implicated in AtlE-mediated biofilm formation on plasma
protein-coated polymer surfaces (Heilmann et al., 1997). Clinical
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MRSA strains that produce ica-independent biofilms require Atl
for primary attachment to polystyrene surfaces (Houston et al.,
2011).
The major autolysin of S. aureus is expressed as a 137.5 kDa
pro-protein which is proteolytically processed to yield a 3.1 kDa
signal sequence, a 17.6 kDa propeptide and two enzymatically
active regions, a 63.3 kDa N-acetylmuramyl-L-alanine amidase
enzyme and a 53.6 kDa endo-β-N-acetylglucosaminidase enzyme
(Oshida et al., 1995). Catalytic activity of the amidase region is
required for PIA-independent proteinaceous biofilm formation
by hospital acquired MRSA (HA-MRSA) strains (Houston et al.,
2011). The protease inhibitor PMSF, which increases the release of
extracellular autolytic enzymes (Fournier andHooper, 2000), and
polyanethole sodium sulfanate, which inhibits autolytic activity
without impairing growth (Wecke et al., 1986; Yabu and Kaneda,
1995), both prevented biofilm formation by HA-MRSA strains
indicating a vital role for both the unprocessed Atl protein and
the active amidase and glucosaminidase enzymes in early MRSA
biofilm formation (Houston et al., 2011).
Construction of enzymatically inactive point mutations within
the active regions of Atl revealed Atl-mediated cell lysis and
the release of extracellular DNA (eDNA) by both the ami-
dase and glucosaminidase regions as the mechanisms of Atl-
mediated biofilm formation (Bose et al., 2012). Several studies
have reported a role for eDNA in the ica-independent healthcare
associated and community acquired MRSA (CA-MRSA) biofilm
phenotypes (Izano et al., 2008; Lauderdale et al., 2010; Houston
et al., 2011). In S. aureus, addition of DNase I to the culture media
inhibited PIA-independent biofilm formation by HA-MRSA but
did not significantly disperse mature MRSA biofilms implicating
eDNA in the attachment and/or early stage of biofilm develop-
ment (Houston et al., 2011). In the CA-MRSA strain USA300,
the secreted thermostable nuclease enzyme, Nuc has also been
shown to negatively impact on biofilm formation (Kiedrowski
et al., 2011). In a mouse model of catheter infections, however,
mutations in nuc and a second nuclease gene nuc2 of the UAMS-
1 MSSA strain were associated with reduced biofilm (Beenken
et al., 2012) indicating that additional studies with MSSA and
MRSA isolates, are needed to fully elucidate the role of these
enzymes and extracellular nucleic acid in the biofilm phenotype
in vivo.
A study of ica-independent mechanisms of biofilm forma-
tion by S. aureus revealed that altered levels of autolysis were
associated with defective biofilm production (Boles et al., 2010).
Recently cytoplasmic proteins released during the stationary
phase of growth, which may be a consequence of autolysis,
have been shown to be part of the biofilm matrix of S. aureus
HG003 (Foulston et al., 2014). Interestingly the release of cyto-
plasmic proteins during stationary phase appears to be in
response to decreasing pH, which can be triggered by the addi-
tion of excess glucose to the growth media (Foulston et al.,
2014) and it is worth noting that these same growth con-
ditions promote Atl/FnBP-mediated MRSA biofilm formation
(O’Neill et al., 2008). A simplified model of MSSA and MRSA
biofilm mechanisms together with scanning electron micro-
graphs of SH1000 (MSSA) and BH1CC (MRSA) biofilms is
presented in Figure 1.
FIGURE 1 | (A) Graphic representations of the biofilm phenotypes
expressed by MSSA and MRSA. MSSA strains form ica-dependent,
PIA-mediated biofilms whereas MRSA strains form biofilms independent of
PIA and require surface proteins such as the fibronectin binding proteins,
Atl-mediated cell lysis and eDNA for colonization of surfaces and biofilm
accumulation. (B) Scanning electron micrographs (3500 × magnification) of
biofilms formed by MSSA strain SH1000 grown in BHI media
supplemented with 4% NaCl (left) and MRSA strain BH1CC grown in BHI
supplemented with 1% glucose (right).
HOW DOES METHICILLIN RESISTANCE AFFECT THE BIOFILM
PHENOTYPE AND VIRULENCE?
METHICILLIN RESISTANCE AND BIOFILM
The mechanism(s) underpinning the association between the
MRSA and MSSA biofilm phenotypes and utilization of polysac-
charide and protein adhesins, respectively remains unclear.
However, the level of resistance to beta-lactam antibiotics appears
to be important for the biofilm phenotype. For instance, excision
of the SCCmec element from the hospital MRSA strain BH1CC
was associated with reduced FnBP-mediated biofilm forming
capacity, presumably due to up-regulated protease activity (Pozzi
et al., 2012; Rudkin et al., 2012). The relationship between methi-
cillin resistance and biofilm is further complicated by the observa-
tion that MRSA strains can express either low level heterogeneous
resistance (HeR) to methicillin or high-level, homogeneous resis-
tance (HoR) (Keaton et al., 2013; Mwangi et al., 2013). Carriage
of the mecA gene alone does not confer the HoR phenotype
and additional genetic events are also needed (Pozzi et al., 2012;
Mwangi et al., 2013; Dordel et al., 2014). In the laboratory iso-
lation of homogeneously resistant strains from HeR strains is
readily achieved by plating cell suspensions on media supple-
mented with high concentrations of oxacillin, the clinically used
derivative of methicillin (100μg/ml) (Pozzi et al., 2012; Dordel
et al., 2014). In clinical isolates of MRSA the ica locus is present
and expressed but PIA does not appear to be produced (O’Neill
et al., 2007). In an engineered derivative of the laboratory strain
8325-4 carrying themecA gene on a plasmid and expressing HoR,
the ica operon was repressed >300-fold compared to its MSSA
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parent and was associated with a switch from PIA-dependent to
proteinaceous biofilm (Pozzi et al., 2012). In contrast expression
of HeR in 8325-4 did not significantly alter the biofilm phenotype
(Pozzi et al., 2012). Extracellular protease activity was reduced in
the 8325-4 HoR strain and 8235-4 HoR biofilms were dispersed
with proteinase K implicating a protein adhesin in this pheno-
type (Pozzi et al., 2012). However, because this biofilm phenotype
was independent of PIA/PNAG, the major autolysin or any of the
LPXTG cell wall anchored proteins whereas clinical MRSA iso-
lates express an FnBP/eDNA dependent biofilm, it appears that
expression of homogeneous methicillin resistance is associated
with at least two distinct biofilm phenotypes. It remains to be
determined whether PBP2a expression exerts direct or indirect
(e.g., via altered cell wall architecture) effects on biofilm produc-
tion. In a murine device infection model 8325-4 and 8325-4 HoR
were recovered in similar numbers from implanted catheters, sug-
gesting that PIA/PNAG and protein adhesin-mediated biofilms
may be equally effective for device colonization in vivo (Pozzi
et al., 2012).
OXACILLIN RESISTANCE AND VIRULENCE
High level PBP2a expression in MRSA is associated with repres-
sion of the Agr quorum sensing operon (Pozzi et al., 2012; Rudkin
et al., 2012). Agr repression in MRSA is directly linked to mecA
expression and the subsequent changes in cell wall architecture
are accompanied by reduced cytotoxin production and attenu-
ated virulence. The repression of Agr blocks the co-ordinated
switch-on of toxin and enzyme secretion during the latter stages
of bacterial growth in vitro, leaving the cell arrested in the surface
protein expression stage of the Agr regulatory cycle (Rudkin et al.,
2012). As noted above, increased surface protein expression and
repression of extracellular protease production are also consistent
with the protein-mediated MRSA biofilm phenotype (Pozzi et al.,
2012).
Murine infection model studies showed that mice infected
with the 8325-4 HoR strain were more likely to survive than
mice infected with 8325-4 (Pozzi et al., 2012). The 8325-4 HoR
strain did not significantly disseminate beyond the surround-
ing peri-catheter tissue whereas high numbers of the 8235-4
MSSA strain were recovered from the kidneys, liver and spleen
(Pozzi et al., 2012). In a murine bacteremia model, mice infected
with SCCmec and mecA mutants of the HA-MRSA strain
BH1CC consistently lost more weight during the course of infec-
tion and suffered >60% mortality compared to the wild type
(Rudkin et al., 2012). These data have led to the hypothesis that
MRSA strains have sacrificed virulence for high level antibiotic
resistance. Supporting this idea, the infectivity and lethality of
MRSA strains was also reduced in guinea pig and murine mod-
els of infection compared to MSSA strains (Mizobuchi et al.,
1994). Interestingly, MRSA and MSSA isolates were equally vir-
ulent in immunocompromised animals (Mizobuchi et al., 1994).
Furthermore, a study of 104 patients with S. aureus bacteremia
found that MSSA bacteremia correlated with significantly higher
rates of infective endocarditis than MRSA (Abraham et al., 2004).
Similarly, MSSA infections have been associated with a signif-
icantly higher illness severity score from invasive disease than
MRSA clones (Wehrhahn et al., 2012).
The phenol soluble modulin mec (psm-mec) locus located
adjacent to mecA on type II SCCmec elements promotes biofilm
formation in MRSA strains (Kaito et al., 2011, 2013) and has also
been implicated in reduced virulence of MRSA strains in murine
models of infection (Kaito et al., 2008, 2011; Queck et al., 2009).
The psm-mec locus was directly implicated in inhibiting trans-
lation of the agrA transcript (Kaito et al., 2013). Interestingly
carriage of psm-mec was only associated with HA-MRSA strains
and was absent in the more virulent CA-MRSA isolates and
mutation or deletion of the locus from HA-MRSA increased vir-
ulence capacity in murine infection models (Kaito et al., 2013).
In addition to PSM-mec, phenol soluble modulins (PSMs) gen-
erally have surfactant qualities and are known to be centrally
involved in biofilm structuring and detachment, including dis-
semination of biofilm-associated infection (Wang et al., 2011;
Periasamy et al., 2012). In this context, repression of the Agr sys-
tem including PSM-mec in MRSA is consistent with enhanced
biofilm formation.
Oxacillin resistance has pleiotropic effects on S. aureus, chang-
ing the biofilm phenotype, altering global gene regulation, reduc-
ing toxin production and ultimately reducing virulence. However,
the importance of MRSA strains as pathogens in healthcare
and community setting reflects the high degree of adaptation
of S. aureus to methicillin resistance and the associated cellu-
lar changes. The attenuated virulence associated with high level
resistance in HA-MRSA strains, is consistent with their confine-
ment within healthcare settings (Collins et al., 2010; Rudkin et al.,
2012), whereas the resistance/virulence equilibrium in CA-MRSA
strains has clearly supported their ability in infect otherwise
healthy individuals.
NUCLEOTIDE SIGNALING AND METHICILLIN RESISTANCE
The mechanisms underpinning the relationship between antibi-
otic resistance and virulence in S. aureus remain to be elucidated
but studies over recent years implicate nucleotide signaling in
these phenotypes. Mutation of the S. aureus diadenylate cyclase
gene dacA, which reduced c-di-AMP levels, resulted in the con-
version of a HoR MRSA to a HeR strain (Dengler et al., 2013).
Conversely mutations in the gdpP-encoded c-di-AMP phospho-
diesterase, which resulted in increased c-di-AMP levels were
accompanied by HoR to methicillin (Corrigan et al., 2011; Pozzi
et al., 2012) or increased tolerance to beta-lactam antibiotics
(Griffiths and O’Neill, 2012). In Bacillus subtilis, the activity
of the GdpP homolog YybT is strongly repressed by the strin-
gent response alarmone ppGpp, which is synthesized by the
RelA enzyme (Rao et al., 2010) and Mwangi et al. reported
that activation of the stringent response and constitutive ppGpp
production was accompanied by homogeneous methicillin resis-
tance (Mwangi et al., 2013). Proteomic analysis has revealed
that aminoacyl-tRNA biosynthesis was repressed by subinhibitory
concentrations of oxacillin in both MSSA and MRSA (Liu et al.,
2014). Reduced levels of aminoacyl-tRNA may trigger the strin-
gent response, which is normally activated by amino acid starva-
tion and specifically the concomitant reduction in charged tRNA
levels. A recent genomics analysis of HoR strains derived from a
range of clinical HeR isolates identified mutations in 27 genes and
3 intergenic regions, most of which are potentially involved in the
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stringent response (Dordel et al., 2014). Collectively these data
implicate the stringent response in the HoR phenotype and may
suggest that ppGpp-mediated repression of GdpP activity leads
to reduced c-di-AMP levels and in turn modulates resistance to
beta-lactam antibiotics, biofilm and virulence. Identification of
c-di-AMP targets may help elucidate the mechanism c-di-AMP-
controlled beta-lactam resistance and initial studies to identify
c-di-AMP target proteins identified in S. aureus and Listeria
monocytogenes suggest a pleiotrophic role for this nucleotide
second messenger (Corrigan et al., 2013; Sureka et al., 2014).
CONCLUDING THOUGHTS
Biofilm formation is a key virulence factor of staphylococci and
distinct mechanisms are employed by MSSA and MRSA for
biofilm formation. Clinical MSSA strains predominantly form
biofilm dependent on the icaADBC operon and PIA produc-
tion whereas MRSA strains form biofilms independent of PIA
(O’Neill et al., 2007). There are important roles for LPXTG-
anchored surface proteins, the major autolysin and eDNA during
MRSA biofilm formation in the absence of PIA (O’Neill et al.,
2008; Houston et al., 2011). Acquisition of methicillin resis-
tance appears to repress polysaccharide-type biofilm production
and promote formation of proteinaceous-type biofilms (Pozzi
et al., 2012).While the different mechanisms of biofilm formation
employed byMSSA andMRSA do not appear to impair the ability
of either to colonize implanted biomaterial in vivo, the acquisi-
tion of methicillin resistance by HA-MRSA is associated with an
overall downregulation of virulence gene expression (Pozzi et al.,
2012; Rudkin et al., 2012, 2014). Despite this, HA-MRSA strains
remain a significant cause of morbidity and mortality for hos-
pitalized patients perhaps reflecting their successful adaptation
to a specific niche within the hospital setting where there is a
large pool of immunocompromised individuals that often require
implanted medical devices and intensive antibiotic treatments
(Pozzi et al., 2012). Understanding how MRSA has remained a
successful pathogen in the hospital environment, will inform the
development of novel therapeutics. Indeed treating MRSA strains
with oxacillin may still have therapeutic potential (Rudkin et al.,
2014). In CA-MRSA strains, the lower levels of PBP2a expres-
sion compared to HA-MRSA is associated with maintenance of
high level toxin production. Using oxacillin to increase PBP2a
expression can repress Agr activity and secretion of cytolytic tox-
ins, indicating therapeutic potential (Rudkin et al., 2014). Further
investigations to assess the global impact of oxacillin treatment
on MRSA gene expression are needed but these data illustrate
how advances in our understanding of antibiotic resistance and
biofilm might be exploited in the development of new strategies
to better prevent and treat S. aureus infections.
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